Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Genvion has added to its contract development and manufacturing knowledge with the addition of new spray drying and Wurster coating technology.
read more
CRF Health announced the company has been recognized as 2018 New Entrant of the Year in Romania’s Regional IT & Outsourcing Industry Awards, (also known as the PIN Awards).
read more
Bioasis and Wuxi Biologics announced an initial strategic collaboration for the development and manufacturing of xB3-001, Bioasis’ lead investigational biological candidate to treat brain cancer.
read more
The U.S. Food & Drug Administration (FDA) scientists recently discovered an inaccuracy in certain data provided to the agency by the IQVIA National Sales Perspectives database, including data on certain opioid drug products.
read more
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Vectalys and FlashCell have merged to create Flash Therapeutics, a new privately held gene therapy company developing gene and cell therapeutics.
read more
Thermo Fisher Scientific announced Astex Pharmaceuticals selected the Thermo Scientific Glacios Cryo Transmission Electron Microscope to aid in its drug discovery and development program.
read more
DelMar Pharmaceuticals announced its financial results for the third quarter ended March 31, 2018.
read more
Granules announced the U.S. FDA has approved its Abbreviated New Drug Applications for Methylergonovine 0.2 mg tablets.
read more
Catalent Pharma Solutions has completed the second phase of a $5.5 million expansion program at its Kansas City, Missouri facility.
read more
Eiger has expanded its licensing agreement with Merck to include rights to develop the investigational farnesyltransferase inhibitor lonafarnib for the treatment of Hutchinson-Gilford Progeria Syndrome.
read more
TEDOR Pharma announced the closing of a recapitalization and reorganization of its business, funded by investments from DORA Ventures.
read more
Sinclair Research has announce new executive leadership with the arrival of Mark Lane, as director of business development.
read more
BioLife Solutions announced a $1 million equity investment in SAVSU Technologies, a designer and manufacturer of high-performance cloud-connected storage and transport containers optimized for the cell and gene therapy supply chain.
read more
Excelra Knowledge Solutions and IIT-Kharagpur announce a multi-year collaboration aimed at accelerating research in drug repurposing.
read more